Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer Publisher

Modarres MP¹ ; Habibi MA^{2, 3} ; Pashaei MR⁴ ; Mohammadpour Y⁵ ; Jazi K³ ; Ahmadpour S⁴

Source: Current Cancer Therapy Reviews Published:2025

Abstract

Colorectal cancer (CRC) is a commonly diagnosed cancer responsible for numerous deaths worldwide. In recent decades, technological advances implicated in considering the molecular pathways underlying CRC pathogenesis. Several investigations have identified various mechanisms involved in CRC and have paved the way for new therapeutics and early diagnosis. Gut microbiome play a crucial role in intestinal inflammation and can be associated with colitis colorectal cancer. In this review, we narrated the role of the microbiome population and their metabolome profile as a new screening method for early detection of CRC. © 2025 Bentham Science Publishers.

Related Docs

View other Related Docs

1. Bacterial Biomarkers: New Aspects of Colorectal Tumors Diagnosis: Reality or Fantasy, European Journal of Cancer Prevention (2023)

2. Role of Gut Microbiota in the Pathogenesis of Colorectal Cancer; a Review Article, Gastroenterology and Hepatology from Bed to Bench (2018)

3. Association of Lactobacillus, Firmicutes, Bifidobacterium, Clostridium, and Enterococcus With Colorectal Cancer in Iranian Patients, Heliyon (2023)

Experts (# of related papers)

View all Related Experts

Mohammad Mehdi Feizabadi (5)

Mohammad Sadegh Fazeli (2)

Other Related Docs

4. Exploring the Interplay Between Fusobacterium Nucleatum With the Expression of Microrna, and Inflammatory Mediators in Colorectal Cancer, Frontiers in Microbiology (2023)

5. Gut Microbiota, Epigenetic Modification and Colorectal Cancer, Iranian Journal of Microbiology (2017)

6. Significant Difference in Gut Microbiota Bifidobacterium Species But Not Lactobacillus Species in Colorectal Cancer Patients in Comparison With Healthy Volunteers Using Quantitative Real-Time Pcr, PLoS ONE (2024)

7. Evaluation of Enterotoxigenic Bacteroides Fragilis Correlation With the Expression of Cellular Signaling Pathway Genes in Iranian Patients With Colorectal Cancer, Infectious Agents and Cancer (2023)

8. Alterations in the Gut Microbiota and Their Metabolites in Human Intestinal Epithelial Cells of Patients With Colorectal Cancer, Molecular Biology Reports (2024)

9. Oral Microbiota As Novel Biomarkers for Colorectal Cancer Screening, Cancers (2023)

10. 16S Rrna Sequencing Analysis of the Oral and Fecal Microbiota in Colorectal Cancer Positives Versus Colorectal Cancer Negatives in Iranian Population, Gut Pathogens (2024)

11. Applying Simple Linear Combination, Multiple Logistic and Factor Analysis Methods for Candidate Fecal Bacteria As Novel Biomarkers for Early Detection of Adenomatous Polyps and Colon Cancer, Journal of Microbiological Methods (2018)

12. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer, International Archives of Allergy and Immunology (2022)

13. Fusobacterium Nucleatum and Colorectal Cancer: A Mechanistic Overview, Journal of Cellular Physiology (2019)

14. Enterotoxigenic Bacteroides Fragilis: A Possible Etiological Candidate for Bacterially-Induced Colorectal Precancerous and Cancerous Lesions, Frontiers in Cellular and Infection Microbiology (2020)

15. Toxigenic and Non-Toxigenic Patterns I, Ii and Iii and Biofilm-Forming Ability in Bacteroides Fragilis Strains Isolated From Patients Diagnosed With Colorectal Cancer, Gut Pathogens (2020)

16. The Association of Oral Microbiome Dysbiosis With Gastrointestinal Cancers and Its Diagnostic Efficacy, Journal of Gastrointestinal Cancer (2023)

17. Fecal Profiling Reveals a Common Microbial Signature for Pancreatic Cancer in Finnish and Iranian Cohorts, Gut Pathogens (2025)

18. Colorectal Cancer: Epidemiology, Risk Factors, and Prevention, Cancers (2024)

19. A Metabolic Model of Intestinal Secretions: The Link Between Human Microbiota and Colorectal Cancer Progression, Metabolites (2021)

20. Bacterial Biofilm in Colorectal Cancer: What Is the Real Mechanism of Action?, Microbial Pathogenesis (2020)

Style	Citing Format
MLA	Modarres MP, et al.. "Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer." Current Cancer Therapy Reviews, vol. 21, no. 1, 2025, pp. 10-22.
APA	Modarres MP, Habibi MA, Pashaei MR, Mohammadpour Y, Jazi K, Ahmadpour S (2025). Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer. Current Cancer Therapy Reviews, 21(1), 10-22.
Chicago	Modarres MP, Habibi MA, Pashaei MR, Mohammadpour Y, Jazi K, Ahmadpour S. "Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer." Current Cancer Therapy Reviews 21, no. 1 (2025): 10-22.
Harvard	Modarres MP et al. (2025) 'Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer', Current Cancer Therapy Reviews, 21(1), pp. 10-22.
Vancouver	Modarres MP, Habibi MA, Pashaei MR, Mohammadpour Y, Jazi K, Ahmadpour S. Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer. Current Cancer Therapy Reviews. 2025;21(1):10-22.
BibTex	@article{ author = {Modarres MP and Habibi MA and Pashaei MR and Mohammadpour Y and Jazi K and Ahmadpour S}, title = {Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer}, journal = {Current Cancer Therapy Reviews}, volume = {21}, number = {1}, pages = {10-22}, year = {2025} }
RIS	TY - JOUR AU - Modarres MP AU - Habibi MA AU - Pashaei MR AU - Mohammadpour Y AU - Jazi K AU - Ahmadpour S TI - Alterations of the Gut Microbiome and Metabolome Following: A Opportunity for Early Detection of Colorectal Cancer JO - Current Cancer Therapy Reviews VL - 21 IS - 1 SP - 10 EP - 22 PY - 2025 ER -

Science Communicator Platform

Authors

Abstract